Point72 Asset Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Point72 Asset Management's RXST Position: Q2 2026 in Review
Point72 Asset Management increased its RxSight (RXST) stake by 6.1% in Q2 2026, buying an estimated $271K and bringing the position to 778,252 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1968.
Point72 Asset Management first reported a position in RXST in Q1 2022 and has held it in 16 quarters since. The position peaked at $22.1M in Q3 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- Point72 Asset Management held 778,252 shares of RxSight worth $3.75M as of Q2 2026.
- Point72 Asset Management bought 44,945 RxSight shares in Q2 2026, an estimated $271K.
- RxSight made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1968 holding.
- Point72 Asset Management first reported a position in RxSight in Q1 2022 and has held it in 16 quarters since.
- Point72 Asset Management's RxSight position peaked at $22.1M in Q3 2024.
- 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.